2022-01-24 - Cancer Synoptic Reporting Project Group Meeting

1. Focus on synoptic reporting uses.
2. Examples:
   1. Breast cancer her2 from breast tissue
   2. breast cancer her2 from lymph node
   3. breast cancer her2 from any tissue

b. her2 in breast cancer from lymph node

c. her2 in breast cancer from any tissue site specimen

Conclusion to this good discussion is that there exists a need to develop a mechanism to note an observation made that is a proxy statement - specifically, an observation about a primary neoplasm location made on a metastatic specimen.

Alternatively, be less specific in these observations and rely more upon the info model.

Continue discussion:

What are we measuring when assessing "treatment effect"?  

Is this a histologic change?  Viability of tumor cells?

1. Primary site
2. Lymph node